Skip to main content

Breast Cancer Stem Cells: A Clinician’s View

  • Protocol
  • First Online:
Mammary Stem Cells

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2471))

  • 1059 Accesses

Abstract

Much has been revealed about breast cancer stem cells, their properties, and behavior and yet, a gap remains between the ever expanding knowledge and its effective clinical applications. The previous chapters have illustrated the extraordinary wealth of methodologies presently used to continue improving our understanding of breast cancer stem cells. The hope is that soon all this knowledge will translate into applicable improvements in the clinic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pavlopoulou Y, Oktay K, Vougas M, Louka CE, Vorgias AGG (2016) Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells. Cancer Lett 380:485–493

    Article  CAS  Google Scholar 

  2. Pattabiraman DR, Weinberg RA (2014) Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov 13:497–512

    Article  CAS  Google Scholar 

  3. Peitzsch A, Tyutyunnykova K, Pantel A (2017) Dubrovska, cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol 44:10–24

    Article  CAS  Google Scholar 

  4. Eiro N, Gonzalez LO, Fraile M, Cid S, Schneider J, Vizoso FJ (2019) Breast cancer tumor stroma: cellular components, phenotypic heterogeneity, intercellular communication, prognostic implications and therapeutic opportunities. Cancers (Basel) 11(5):664I

    Article  Google Scholar 

  5. Baccelli A, Schneeweiss S, Riethdorf A, Stenzinger A, Schillert VV et al (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31:539–544

    Article  CAS  Google Scholar 

  6. Scheel C, Weinberg RA (2012) Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22:396–403

    Article  CAS  Google Scholar 

  7. Dittmer J (2018) Breast cancer stem cells: features, key drivers and treatment options. Semin Cancer Biol 53:59–74

    Article  Google Scholar 

  8. Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y et al (2014) Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports 2:78–91

    Article  CAS  Google Scholar 

  9. D’Angelo RC, Ouzounova M, Davis A, Choi D, Tchuenkam SM, Kim G et al (2015) Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity. Mol Cancer Ther 14:779

    Article  Google Scholar 

  10. Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F (2012) Radiation-induced reprogramming of breast cancer cells. Stem Cells 30:833–844

    Article  CAS  Google Scholar 

  11. Bui QT, Im JH, Jeong SB, Kim YM, Lim SC, Kim B et al (2017) Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer. Cancer Lett 390:115–125

    Article  CAS  Google Scholar 

  12. Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, Cui H (2020) Targeting stem cell pathways for cancer therapy. Signal Transduct Target Ther 5:8

    Article  Google Scholar 

  13. Costa LA, Eiro N, Fraile M, Gonzalez LO, Saá J, Garcia-Portabella P, Vega B, Schneider J, Vizoso FJ (2020) Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses. Cell Mol Life Sci 22:1–21

    Google Scholar 

  14. Eiró N, Sendon-Lago J, Seoane S, Bermúdez MA, Lamelas ML, Garcia-Caballero T, Schneider J, Perez-Fernandez R, Vizoso FJ (2014) Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells. Oncotarget 5:10692–10708

    Article  Google Scholar 

  15. Schneider J, Eiró N, Pérez-Fernández R, Martínez-Ordóñez A, Vizoso F (2016) Human uterine cervical stromal stem cells (hUCESCs): why and how they exert their antitumor activity. Cancer Genomics Proteomics 13:331–337

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose Schneider .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Schneider, J., Vizoso, F.J. (2022). Breast Cancer Stem Cells: A Clinician’s View. In: Vivanco, M.d. (eds) Mammary Stem Cells. Methods in Molecular Biology, vol 2471. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2193-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-2193-6_20

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2192-9

  • Online ISBN: 978-1-0716-2193-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics